- Home
- JAZZ
as 11-15-2024 10:35am EST
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
| Founded: | 2003 | Country: | Ireland |
| Employees: | N/A | City: | DUBLIN |
| Market Cap: | 6.5B | IPO Year: | 2007 |
| Target Price: | $173.57 | AVG Volume (30 days): | 613.8K |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 7.04 | EPS Growth: | 458.10 |
| 52 Week Low/High: | $99.06 - $134.17 | Next Earning Date: | 11-06-2024 |
| Revenue: | $3,992,712,000 | Revenue Growth: | 5.23% |
| Revenue Growth (this year): | 7.43% | Revenue Growth (next year): | 6.39% |
Stock Insider Trading Activity of Jazz Pharmaceuticals plc (Ireland) (JAZZ)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Henderson Mary Elizabeth | JAZZ | SVP, Technical Operations | Sep 6 '24 | Sell | $108.30 | 1,410 | $152,703.00 | 14,531 |
Latest Jazz Pharmaceuticals plc (Ireland) News
JAZZ Breaking Stock News: Dive into JAZZ Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Is the Options Market Predicting a Spike in Jazz (JAZZ) Stock?
Simply Wall St.
a day ago
Jazz Pharmaceuticals' (NASDAQ:JAZZ) Performance Is Even Better Than Its Earnings Suggest
MT Newswires
2 days ago
Jazz Pharmaceuticals Insider Sold Shares Worth $456,617, According to a Recent SEC Filing
Zacks
2 days ago
Jazz (JAZZ) Upgraded to Buy: Here's Why
Zacks
2 days ago
JAZZ or CTLT: Which Is the Better Value Stock Right Now?
Zacks
2 days ago
Wall Street Analysts See a 37.65% Upside in Jazz (JAZZ): Can the Stock Really Move This High?
Zacks
2 days ago
Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now?
Argus Research
3 days ago
JAZZ: Raising target price to $134.00
Compare JAZZ vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "JAZZ Jazz Pharmaceuticals plc (Ireland) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.